Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
(2016)
Journal Article
McGarvey, L., Morice, A. H., Smith, J. A., Birring, S. S., Chuecos, F., Seoane, B., & Jarreta, D. (2016). Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials. BMJ Open Respiratory Research, 3(1), Article e000148. https://doi.org/10.1136/bmjresp-2016-000148
© 2016, BMJ Publishing Group. All rights reserved. Background: Cough and sputum are troublesome symptoms in chronic obstructive pulmonary disease (COPD) and are associated with adverse outcomes. The efficacy of aclidinium bromide 400 μg twice daily i... Read More about Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials.